Cargando…

Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker

Immunoglobulin M multiple myeloma (IgM MM) is an extremely rare subtype of multiple myeloma with a poor clinical outcome. In this study, bone marrow aspirates of MM patients, including two cases of IgM MM, were analyzed by whole exome sequencing and RNA sequencing. Recurrent somatic mutations in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryu, Daeun, Kim, Hee Jin, Joung, Je-Gun, Lee, Hae-Ock, Bae, Joon Seol, Kim, Seok Jin, Kim, Haesu, Park, Woong-Yang, Kim, Kihyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216929/ https://www.ncbi.nlm.nih.gov/pubmed/27223072 http://dx.doi.org/10.18632/oncotarget.9478

Ejemplares similares

Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis
por: Kim, Seok Jin, et al.
Publicado: (2016)

Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis
por: Lee, Ji Young, et al.
Publicado: (2021)

Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
por: Kim, Kihyun, et al.
Publicado: (2013)

Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens
por: Joung, Je-Gun, et al.
Publicado: (2016)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
por: Song, Ga-Young, et al.
Publicado: (2022)

Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
por: Ebana, Hideaki, et al.
Publicado: (2014)

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea
por: Kim, Hyo Jung, et al.
Publicado: (2015)

Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma
por: Joung, Je-Gun, et al.
Publicado: (2016)

Association between Serum Varicella-Zoster Virus IgM and IgG and Prognosis of Ramsay Hunt Syndrome
por: Chung, Seok Hwan, et al.
Publicado: (2023)

The Diagnostic and Treatment Challenges of Concomitant Mantle Cell Lymphoma and IgM Myeloma
por: Gor, Dhairya, et al.
Publicado: (2022)

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
por: Jung, Sung-Hoon, et al.
Publicado: (2016)

Anti-HBc IgM and anti-delta screening by EIA method.
por: Kim, J. S., et al.
Publicado: (1986)

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
por: Liu, Jin, et al.
Publicado: (2020)

Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test
por: Hyun, Jong Jin, et al.
Publicado: (2012)

Progressive Multifocal Leukoencephalopathy With Hyper-IgM Syndrome in a 6-Year-Old Boy
por: Kim, Han Su, et al.
Publicado: (2022)

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
por: Byun, Ja Min, et al.
Publicado: (2022)

Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity
por: Bonilla-Valentín, Fernando Javier, et al.
Publicado: (2018)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)
por: Lee, Ho Sup, et al.
Publicado: (2020)

Assay Sensitivity Difference Can Induce Anti-Hepatitis A Virus IgM Non-Reactive But Total (IgM and IgG) Reactive Results in Early Acute Hepatitis A
por: Kim, Soo-Kyung, et al.
Publicado: (2022)

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
por: Kim, Seok Jin, et al.
Publicado: (2016)

Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer()()
por: Yun, Jae Won, et al.
Publicado: (2018)

Hemolysis-Inspired, Highly Sensitive, Label-Free IgM Detection Using Erythrocyte Membrane-Functionalized Nanomechanical Resonators
por: Lee, Taeha, et al.
Publicado: (2022)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2020)

Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report
por: Kim, Jin Hae, et al.
Publicado: (2015)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity
por: Park, Man-Seok, et al.
Publicado: (2005)

Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data
por: Fan, Jean, et al.
Publicado: (2018)

First Case of Plasma Cell Myeloma With Brown Tumor Features Unrelated to Hyperparathyroidism
por: Kim, Heyjin, et al.
Publicado: (2019)

Biclonal IgD and IgM Plasma Cell Myeloma: A Report of Two Cases and a Literature Review
por: Chen, Zhongchuan W., et al.
Publicado: (2013)

Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
por: Kim, Hyun-Young, et al.
Publicado: (2022)

Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma—A case report
por: Gauckler, Philipp, et al.
Publicado: (2020)

Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP
por: Jung, Hyunchul, et al.
Publicado: (2018)

The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP
por: Jung, Hyunchul, et al.
Publicado: (2017)

IgM nephropathy revisited
por: Mubarak, Muhammed, et al.
Publicado: (2012)

IgM’s exit route
por: Reversat, Anne, et al.
Publicado: (2018)

DETECTION OF MEASLES IgM
por: Lievens, Alan W, et al.
Publicado: (1984)

IgG, IgM, and IgA Antinuclear Antibodies in Discoid and Systemic Lupus Erythematosus Patients
por: Jost, Sheridan A., et al.
Publicado: (2014)

Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study
por: Kwon, Jihyun, et al.
Publicado: (2016)

Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM
por: Lee, Hyeok-Jin, et al.
Publicado: (2010)

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
por: Lee, Yoo Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bsquerjmrq3c1jnpucc4sov4in